CRISPR

CRISPR1-hspa13

ID

ZDB-CRISPR-180703-3

Name

CRISPR1-hspa13

Previous Names

Z001432 (1)

Target

hspa13 (1)

Sequence

5' - GGGTCATTGGGCTGGATCTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
hg78	hspa13
hg79	hspa13

Expression

Gene expression in Wild Types + CRISPR1-hspa13

No data available

Phenotype

Phenotype resulting from CRISPR1-hspa13

No data available

Phenotype of all Fish created by or utilizing CRISPR1-hspa13

Phenotype	Fish	Conditions	Figures
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal	hspa13^hg78/hg78	chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell	Fig. 3 from Pei et al., 2018
swim bladder uninflated, abnormal	hspa13^hg78/hg78	standard conditions	Fig. 2 from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal	hspa13^hg78/hg78	chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell	Fig. 3 from Pei et al., 2018
ventral fin fold regeneration disrupted, abnormal	hspa13^hg78/hg78	amputation: ventral fin fold	Fig. 4 from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal	hspa13^hg79/hg79	chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell	Fig. 3 from Pei et al., 2018
swim bladder uninflated, abnormal	hspa13^hg79/hg79	standard conditions	Fig. 2 from Pei et al., 2018
ventral fin fold regeneration disrupted, abnormal	hspa13^hg79/hg79	amputation: ventral fin fold	Fig. 4 from Pei et al., 2018
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal	hspa13^hg79/hg79	chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell	Fig. 3 from Pei et al., 2018
liver regeneration disrupted, abnormal	hspa13^hg78/hg78; s931Tg/+	chemical ablation: liver, chemical treatment: metronidazole	Fig. 5 from Pei et al., 2018
liver decreased size, abnormal	hspa13^hg78/hg78; s931Tg/+	chemical ablation: liver, chemical treatment: metronidazole	Fig. 5 from Pei et al., 2018
liver regeneration disrupted, abnormal	hspa13^hg79/hg79; s931Tg/+	chemical ablation: liver, chemical treatment: metronidazole	Fig. 5 from Pei et al., 2018
liver decreased size, abnormal	hspa13^hg79/hg79; s931Tg/+	chemical ablation: liver, chemical treatment: metronidazole	Fig. 5 from Pei et al., 2018

Citations